Mg OSTEOCRETE Post-Treatment Outcomes

Recruiting now

Conditions studied: Cancer of Bone, Trauma, Aseptic Loosening of Orthopaedic Hardware

In brief

Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.

Key facts

Study ID

NCT06720142

Run by

Santiago Lozano-Calderon

People needed

10

Starts

2025-03-17

Expected to finish

2028-03-17

Last updated by the study team

2026-04-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age and older on the day of surgery
• has received or will receive Mg OSTEOCRETE as a component of their treatment at this institution in accordance with Instructions for Use for the implanted product
• Mg OSTEOCRETE is indicated for one of the following reasons:
• as a bone void filler following bone tumor resection, or;
• as an augment for defects causing aseptic loosening of orthopaedic implants, or;
• to help substitute bone for trauma-related conditions

You may not qualify if…

• any contraindication as per Instructions for Use for Mg OSTEOCRETE

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.